News

Pharmacelera: 2019 Summary

Posted on
calendar_with_phamacelera_logo_and_2019_year_to_show_summary_of_the_year

2019 was an exciting year for Pharmacelera and we look forward to 2020 with energy and commitment. Stay tuned for updates in forthcoming months! Let’s have a look to the 2019 summary! Collaborations and Partnerships This year has been very productive for us. For example, we have started a new collaboration with a top 10 […]

News

IDIBELL and Pharmacelera sign a research agreement to find new drugs with anticancer applications

Posted on

Researchers at Bellvitge Biomedical Research Institute will develop a research project with the company Pharmacelera to look for new molecules that block the cohesin complex, with applications in several difficult-to-treat cancers, such as myeloid leukemia, glioblastomas, Ewing sarcomas, colon cancer and bladder cancer. The cell cycle research group of the Bellvitge Biomedical Research Institute (IDIBELL), […]

News

Agreement with Universitat Autònoma de Barcelona (UAB) in drug discovery for Parkinson disease

Posted on
Pharmacelera agreement with Universitat Autònoma de Barcelona (UAB) in drug discovery for Parkinson disease

The Universitat Autònoma de Barcelona (UAB) and Pharmacelera have reached an agreement to perform a research project in the area of Parkinson based on the work led by Dr. Salvador Ventura and developed at Institut de Biotecnologia i Biomedicina (IBB). PharmScreen®, Pharmacelera’s flagship software, will be used to perform screening campaigns in huge virtual libraries […]